BNTX Competitors & Alternatives
Compare BioNTech SE with similar stocks in the same industry
Biotechnology
BNTX
Main Stock$92.95
Tradestie Score
51
Market Cap
$24.57B
Revenue Growth
-0.4%
Analyst Upside
+32.5%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$98.63
|
$31.13B | - | 47 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.67
|
$19.56B | 21.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$118.86
|
$16.93B | 16.2 | 59 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.34
|
$15.70B | 31.2 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.21
|
$15.22B | - | 57 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$245.10
|
$12.36B | 29.2 | 54 | Compare |
|
EXEL
Exelixis Inc
|
$54.57
|
$11.09B | 18.5 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.13
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$56.01
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$59.87
|
$10.53B | 43.6 | 53 | Compare |
More BNTX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry